| For: | Shi YH, Shi CH. Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 2009; 15(25): 3099-3105 [PMID: 19575488 DOI: 10.3748/wjg.15.3099] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i25/3099.htm |
| Number | Citing Articles |
| 1 |
Chenggang Shi, Jiyi Huang, Xun Liu, Xiaolin Zeng, Cailian Cheng, Qiongli Yin, Mei Li, Guifeng Cheng. Diagnostic significance of hepatitis B viral antigens in patients with glomerulonephritis-associated hepatitis B virus infection. Diagnostic Microbiology and Infectious Disease 2012; 72(2) doi: 10.1016/j.diagmicrobio.2011.11.003
|
| 2 |
Paul Martin, Daryl T.-Y. Lau, Mindie H. Nguyen, Harry L.A. Janssen, Douglas T. Dieterich, Marion G. Peters, Ira M. Jacobson. A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update. Clinical Gastroenterology and Hepatology 2015; 13(12) doi: 10.1016/j.cgh.2015.07.007
|
| 3 |
Özge Gümüşay, Seren Özenirler, Ayşegül Atak, Cemile Sönmez, Seçil Özkan, Ayşe Fıtnat Tuncel, Güldal Yılmaz, Gülen Akyol. Diagnostic potential of serum direct markers and non‐invasive fibrosis models in patients with chronic hepatitis B. Hepatology Research 2013; 43(3) doi: 10.1111/j.1872-034X.2012.01057.x
|
| 4 |
Simon Peter Kayondo, Josaphat K Byamugisha, Peter Ntuyo. Prevalence of hepatitis B virus infection and associated risk factors among pregnant women attending antenatal clinic in Mulago Hospital, Uganda: a cross-sectional study. BMJ Open 2020; 10(6) doi: 10.1136/bmjopen-2019-033043
|
| 5 |
E. N. Serikova, Yu. V. Ostankova, E. V. Anufrieva, D. E. Reingardt, A. N. Schemelev, E. B. Zueva, A. R. Ivanova, A. V. Semenov, A. A. Totolian. Prevalence of parenteral viral hepatitis B and C markers among migrants in the North-West Federal District. HIV Infection and Immunosuppressive Disorders 2024; 16(3) doi: 10.22328/2077-9828-2024-16-3-94-106
|
| 6 |
Arvin Medhat, Alla Arzumanyan, Mark A. Feitelson. Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma. Oncotarget 2021; 12(24) doi: 10.18632/oncotarget.28077
|
| 7 |
Danielle Alves Gomes Zauli, Carla Lisandre Paula de Menezes, Cristiane Lommez de Oliveira, Elvis Cristian Cueva Mateo, Alessandro Clayton de Souza Ferreira. In-house quantitative real-time PCR for the diagnosis of hepatitis B virus and hepatitis C virus infections. Brazilian Journal of Microbiology 2016; 47(4) doi: 10.1016/j.bjm.2016.07.008
|
| 8 |
Clémence Boivin‐Champeaux, Nieves Velez de Mendizabal, Aksana Jones, Scott Balsitis, Stephan Schmidt, Justin S. Feigelman, Francine Johansson Azeredo. Disease Progression Mathematical Modeling With a Case Study on Hepatitis B Virus Infection. CPT: Pharmacometrics & Systems Pharmacology 2025; 14(3) doi: 10.1002/psp4.13298
|
| 9 |
Irina P Balmasova, Nikolay D Yushchuk, Ospan A Mynbaev, Nageswara R Alla, Elena S Malova, Zhongjie Shi, Chang-Lu Gao. Immunopathogenesis of chronic hepatitis B. World Journal of Gastroenterology 2014; 20(39): 14156-14171 doi: 10.3748/wjg.v20.i39.14156
|
| 10 |
Xiaojing Yu, Yuanling Zheng, Ruoyu Huang, Xiaoran Dai, Guijie Kang, Xuefu Wang, Guoxiu Yan, Biran Ding, Meijuan Zheng, Yuanhong Xu, Lu Zong. Restoration of CD3+CD56+ NKT‐like cell function by TIGIT blockade in inactive carrier and immune tolerant patients of chronic hepatitis B virus infection. European Journal of Immunology 2024; 54(8) doi: 10.1002/eji.202451046
|
| 11 |
Zuzana Vojtechova, Ruth Tachezy, Suchetana Mukhopadhyay. Genome integration of human DNA oncoviruses. Journal of Virology 2025; 99(8) doi: 10.1128/jvi.00562-25
|
| 12 |
Jingui Bao, Yu Lu, Yan Deng, Chengzhi Rong, Yanqiong Liu, Xiuli Huang, Liuying Song, Shan Li, Xue Qin. Association between IL-18 polymorphisms, serum levels, and HBV-related hepatocellular carcinoma in a Chinese population: a retrospective case–control study. Cancer Cell International 2015; 15(1) doi: 10.1186/s12935-015-0223-z
|
| 13 |
Georgia Zeng, Upkar S Gill, Patrick T F Kennedy. Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisis. Gut 2020; 69(11) doi: 10.1136/gutjnl-2020-321627
|
| 14 |
Ying-Hui Shi. Correlation between Hepatitis B Virus Genotypes and Clinical Outcomes. Japanese Journal of Infectious Diseases 2012; 65(6) doi: 10.7883/yoken.65.476
|
| 15 |
Young Min Park. Clinical utility of complex mutations in the core promoter and proximal precore regions of the hepatitis B virus genome. World Journal of Hepatology 2015; 7(1): 113-120 doi: 10.4254/wjh.v7.i1.113
|
| 16 |
Qirong Li, Baozhen Sun, Yue Zhuo, Ziping Jiang, Rong Li, Chao Lin, Ye Jin, Yongjian Gao, Dongxu Wang. Interferon and interferon-stimulated genes in HBV treatment. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1034968
|
| 17 |
Ersan Ozaslan, Tugrul Purnak. Controversies about occult hepatitis B virus infection. World Journal of Gastroenterology 2009; 15(39): 4986-4987 doi: 10.3748/wjg.15.4986
|
| 18 |
Antoanela Curici, Olivia Mioara Ilie, Dana Elena Mindru. Prevalence of HDV, HCV, and HIV Infection in the Population of Patients Infected with HBV in a Romanian Cohort. Microorganisms 2025; 13(1) doi: 10.3390/microorganisms13010118
|
| 19 |
Luisa Barboza, Siham Salmen, Guillermo Teran-Angel, Darrell L. Peterson, Lisbeth Berrueta. A deficient translocation of CD3ζ, ZAP-70 and Grb2 to lipid raft, as a hallmark of defective adaptive immune response during chronic hepatitis B infection. Cellular Immunology 2013; 284(1-2) doi: 10.1016/j.cellimm.2013.05.008
|
| 20 |
Anusha Vittal, Marc G. Ghany. WHO Guidelines for Prevention, Care and Treatment of Individuals Infected with HBV. Clinics in Liver Disease 2019; 23(3) doi: 10.1016/j.cld.2019.04.008
|
| 21 |
Lihong Shen, Yun Zhang, Min Shi, Lijia Shao, Shengchun Feng, Weiting Li, Zhonggang Fang, Jun Yin, Tinghua Li. Performance evaluation of the MAGLUMI Hepatitis B virus surface antigen chemiluminescence immunoassay. Journal of Medical Virology 2024; 96(7) doi: 10.1002/jmv.29817
|
| 22 |
Xiaolei Jiao, Ying Luo, Bin Yang, Li Jing, Yayue Li, Changzheng Liu, Xiang Jing, Fengmei Wang, Yijun Wang, Zhi Du, Yingtang Gao. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker. Infection, Genetics and Evolution 2017; 49 doi: 10.1016/j.meegid.2017.01.008
|
| 23 |
Marta Bes, Victor Vargas, Maria Piron, Natalia Casamitjana, Juan Ignacio Esteban, Nuria Vilanova, Asuncion Pinacho, Josep Quer, Lluis Puig, Jaime Guardia, Silvia Sauleda. T cell responses and viral variability in blood donation candidates with occult hepatitis B infection. Journal of Hepatology 2012; 56(4) doi: 10.1016/j.jhep.2011.11.011
|
| 24 |
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Osamu Yoshida, Julio Aguilar, Guillen Nieto Gerardo, Yoichi Hiasa. Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection. Biomedicines 2023; 11(7) doi: 10.3390/biomedicines11071944
|
| 25 |
Aya Raed Alheany, Shatha Farouk Abdullah. Status of HBeAg in association with other baseline tests in Iraqi patients with CHB. Research Journal of Pharmacy and Technology 2022; doi: 10.52711/0974-360X.2022.00582
|
| 26 |
Sandipan Mukherjee, Arpita Kar, Avik Biswas. Overlapping Transcriptomic Features between Autoimmune Liver Disease and Chronic Hepatitis B Highlight Inflammatory Signatures as Focal Points of Liver Disease Progression and HCC-associated Mortality. Journal of Current Oncological Trends 2025; 2(2) doi: 10.4103/JCOT.JCOT_7_25
|
| 27 |
R.K. Mondal, M. Khatun, S. Ghosh, P. Banerjee, S. Datta, S. Sarkar, B. Saha, A. Santra, S. Banerjee, A. Chowdhury, S. Datta. Immune-driven adaptation of hepatitis B virus genotype D involves preferential alteration in B-cell epitopes and replicative attenuation—an insight from human immunodeficiency virus/hepatitis B virus coinfection. Clinical Microbiology and Infection 2015; 21(7) doi: 10.1016/j.cmi.2015.03.004
|
| 28 |
Onur Gokce, Seren Ozenirler, Aysegul Atak Yucel, Nihan Oruklu, Guldal Yilmaz Esendagli, Sevilay Karahan. Evaluation of serum procollagen C-proteinase enhancer 1 level as a fibrosis marker in patients with chronic hepatitis B. European Journal of Gastroenterology & Hepatology 2018; 30(8) doi: 10.1097/MEG.0000000000001123
|
| 29 |
Ning Wang, Jinli Zheng, Yang Huang, Xingyu Pu, Li Jiang, Jiayin Yang. A Predictive Model to Evaluate the HbeAg Positivity of Chronic Hepatitis B Virus Patients in Clinics: A Cross-Sectional Study. Medicina 2022; 58(9) doi: 10.3390/medicina58091279
|
| 30 |
Nevin Karakus, Serbulent Yigit, Mustafa Kocak, Nihan Bozkurt, Fazilet Duygu. Impact of methylene-tetrahydrofolate reductase gene C677T and A1298C polymorphisms as a risk factor for hepatitis B virus infection. Nucleosides, Nucleotides & Nucleic Acids 2023; 42(9) doi: 10.1080/15257770.2023.2187061
|
| 31 |
Shahrzad Shoraka, Seyed Mahdi Hosseinian, Ayda Hasibi, Amir Ghaemi, Seyed Reza Mohebbi. The role of hepatitis B virus genome variations in HBV-related HCC: effects on host signaling pathways. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1213145
|
| 32 |
Hui Zhang, Jianchun Xian, Yang Li, Li Xiao, Lu Wang, Muhammad Zia-Ul-Haq. Effects of Tenofovir Combined with Recombinant Human Interferon α-2b on Negative Conversion Rate, Liver Function, Immune Status, and Drug Safety in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine 2022; 2022 doi: 10.1155/2022/1889628
|
| 33 |
Young Min Park, Seong Gyu Lee. Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study. World Journal of Gastroenterology 2016; 22(44): 9836-9843 doi: 10.3748/wjg.v22.i44.9836
|
| 34 |
|
| 35 |
Hui Nie, Alison A. Evans, W. Thomas London, Timothy M. Block, Xiangdong David Ren. Quantitative dynamics of hepatitis B basal core promoter and precore mutants before and after HBeAg seroconversion. Journal of Hepatology 2012; 56(4) doi: 10.1016/j.jhep.2011.11.012
|
| 36 |
S. Boumbaly, E. N. Serikova, A. V. Semenov, Yu. V. Ostankova, D. E. Valutite, A. N. Schemelev, E. B. Zueva, T. A.L. Balde, R. R. Baimova, A. A. Totolian. Significance of parenteral viral hepatitis laboratory diagnostics in the Republic of Guinea. Journal of microbiology, epidemiology and immunobiology 2021; 98(4) doi: 10.36233/0372-9311-116
|
| 37 |
Louise Rodrigues, Natalia Freitas, Bhaskar V. Kallakury, Stephan Menne, Severin O. Gudima, G. McFadden. Superinfection with Woodchuck Hepatitis Virus Strain WHVNY of Livers Chronically Infected with Strain WHV7. Journal of Virology 2015; 89(1) doi: 10.1128/JVI.02361-14
|
| 38 |
Daniela Păcurar, Alexandru Dinulescu, Gheorghiță Jugulete, Alexandru-Sorin Păsărică, Irina Dijmărescu. Hepatitis B in Pediatric Population: Observational Retrospective Study in Romania. Life 2024; 14(3) doi: 10.3390/life14030348
|
| 39 |
Sohair K. Sayed, Mohammad A. kobeisy. The relationship between core promoter mutation of hepatitis B virus, viral load and hepatitis B e antigen status in chronic hepatitis B patients. Cellular Immunology 2012; 276(1-2) doi: 10.1016/j.cellimm.2012.03.003
|
| 40 |
Koffi Alain Attia, Ya Henriette Kissi, Stanislas Doffou, Demba Bangoura, Roseline Flora Wilson, Georges Bougha, Fulgence Yao Bathaix, Kouame Alassan Mahassadi, Mohamed Sayegh, Therese N’dri-Yoman. Prevalence of hepatitis B infection and factors associated in children of Ivorian HBsAg carrier subjects. Open Journal of Gastroenterology 2013; 3(04) doi: 10.4236/ojgas.2013.34040
|
| 41 |
C. Gauder, L.N. Mojsiejczuk, L. Tadey, L. Mammana, M.B. Bouzas, R.H. Campos, D.M. Flichman. Role of viral load in Hepatitis B virus evolution in persistently normal ALT chronically infected patients. Infection, Genetics and Evolution 2019; 67 doi: 10.1016/j.meegid.2018.10.017
|
| 42 |
Bernd Koeberlein, Axel zur Hausen, Nuran Bektas, Hanswalter Zentgraf, Ruth Chin, Nguyen Linh Toan, Reinhard Kandolf, Joseph Torresi, C.- Thomas Bock. Hepatitis B virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby contributing to severity of inflammation in the liver. Virus Research 2010; 148(1-2) doi: 10.1016/j.virusres.2009.12.003
|
| 43 |
Nevin Varghese, Amry Majeed, Suraj Nyalakonda, Tina Boortalary, Dina Halegoua-DeMarzio, Hie-Won Hann. Review of Related Factors for Persistent Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma. Cancers 2024; 16(4) doi: 10.3390/cancers16040777
|
| 44 |
Yulia V. Ostankova, Alexander N. Shchemelev, Sanaba Boumbaly, Thierno A. L. Balde, Elena B. Zueva, Diana E. Valutite, Elena N. Serikova, Vladimir S. Davydenko, Vsevolod V. Skvoroda, Daria A. Vasileva, Alexander V. Semenov, Elena V. Esaulenko, Areg A. Totolian. Prevalence of HIV and Viral Hepatitis Markers among Healthcare Workers in the Republic of Guinea. Diagnostics 2023; 13(3) doi: 10.3390/diagnostics13030378
|
| 45 |
Man Li, Zhen-Hua Zhou, Xue-Hua Sun, Xin Zhang, Xiao-Jun Zhu, Shu-Gen Jin, Ya-Ting Gao, Yun Jiang, Yue-Qiu Gao. Hepatitis B core antigen upregulates B7-H1 on dendritic cells by activating the AKT/ERK/P38 pathway: a possible mechanism of hepatitis B virus persistence. Laboratory Investigation 2016; 96(11) doi: 10.1038/labinvest.2016.96
|
| 46 |
Tianju Wang, Chunmei Shen, Liping Chen, Sheng Liu, Yanhong Ji. Association of human leukocyte antigen polymorphisms with occult hepatitis B virus infection in a Shaanxi Han population. The Journal of Gene Medicine 2017; 19(9-10) doi: 10.1002/jgm.2987
|
| 47 |
Yong Jin Jung, Jin‐Wook Kim, Soo Jin Park, Bo Young Min, Eun Sun Jang, Nam Young Kim, Sook‐Hyang Jeong, Cheol Min Shin, Sang Hyub Lee, Young Soo Park, Jin‐Hyeok Hwang, Nayoung Kim, Dong Ho Lee. c‐Myc‐mediated overexpression of miR‐17‐92 suppresses replication of hepatitis B virus in human hepatoma cells. Journal of Medical Virology 2013; 85(6) doi: 10.1002/jmv.23534
|
| 48 |
John R. Brill. Sexually Transmitted Infections in Men. Primary Care: Clinics in Office Practice 2010; 37(3) doi: 10.1016/j.pop.2010.04.003
|
| 49 |
Diren Arda Karaoglu, Meral Uner, Cem Simsek, Ali Osmay Gure, Secil Demirkol-Canli. Transcriptomic Analysis of Hepatitis B Infected Liver for Prediction of Hepatocellular Carcinoma. Biology 2023; 12(2) doi: 10.3390/biology12020188
|
| 50 |
Ban M. Al-Kanaan, Mushtak T.S. Al-Ouqaili, Khalid F.A. Al-Rawi. Detection of cytokines (IL-1α and IL-2) and oxidative stress markers in hepatitis B envelope antigen-positive and -negative chronic hepatitis B patients: Molecular and biochemical study. Gene Reports 2019; 17 doi: 10.1016/j.genrep.2019.100504
|
| 51 |
György Berencsi, Márta Csire. Maternal Fetal Transmission of Human Viruses and their Influence on Tumorigenesis. 2012; doi: 10.1007/978-94-007-4216-1_4
|
| 52 |
Marta Bes, Victor Vargas, Maria Piron, Natalia Casamitjana, Juan Ignacio Esteban, Isabel Campos-Varela, Lluís Puig, Silvia Sauleda. Doubtful Role of <b><i>IL28B</i></b> Polymorphism in Occult Hepatitis B Infection. Intervirology 2015; 58(3) doi: 10.1159/000430444
|
| 53 |
Parham Safaie, Mugilan Poongkunran, Ping-Ping Kuang, Asad Javaid, Carl Jacobs, Daryl TY Lau, Imad Nasser, Rebecca Pohlmann. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(12): 3404-3411 doi: 10.3748/wjg.v22.i12.3404
|
| 54 |
Stefan Wirth. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition. 2022; doi: 10.1007/978-3-030-80068-0_63
|
| 55 |
Yu Lu, Jie Zeng, Shi Yang, Zuojian Hu, Limin Li, Hongli Yu, Xue Qin. Association between the rs9131 and rs3806792 polymorphisms of the CXCL2 gene and the risk of HBV‐related hepatocellular carcinoma in a Guangxi population. Journal of Clinical Laboratory Analysis 2020; 34(8) doi: 10.1002/jcla.23310
|
| 56 |
I. P. Balmasova, R. I. Sepiashvili, E. S. Malova. MOLECULAR BIOLOGY OF HEPATITIS B VIRUS AND IMMUNOPATHOGENESIS OF CHRONIC VIRAL HEPATITIS B. Journal of microbiology, epidemiology and immunobiology 2016; 93(2) doi: 10.36233/0372-9311-2016-2-119-126
|
| 57 |
Areeba H. Rizvi, Mohammad A. Alutaibi, Oyedele A. Adeyi. Practical Liver Pathology. Practical Anatomic Pathology 2025; doi: 10.1007/978-3-031-97506-6_6
|
| 58 |
Md Afsar Ali, S.A. Means, Harvey Ho, Jane Heffernan. Global sensitivity analysis of a single-cell HBV model for viral dynamics in the liver. Infectious Disease Modelling 2021; 6 doi: 10.1016/j.idm.2021.10.003
|
| 59 |
Ferruccio Bonino, Maurizia Rossana Brunetto. Occult Hepatitis B Virus (HBV) Infections: Hepatitis B Surface Antigen (HBsAg) Negative and Primary Occult. Current Hepatitis Reports 2013; 12(2) doi: 10.1007/s11901-013-0164-8
|
| 60 |
Dramane Kania, Laure Ottomani, Nicolas Meda, Marianne Peries, Pierre Dujols, Karine Bolloré, Wendy Rénier, Johannes Viljoen, Jacques Ducos, Philippe Van de Perre, Edouard Tuaillon. Performance of two real-time PCR assays for hepatitis B virus DNA detection and quantitation. Journal of Virological Methods 2014; 201 doi: 10.1016/j.jviromet.2014.01.015
|
| 61 |
Man Li, Zhen-Hua Zhou, Xue-Hua Sun, Xin Zhang, Xiao-Jun Zhu, Shu-Gen Jin, Yun Jiang, Ya-Ting Gao, Cheng-Zhong Li, Yue-Qiu Gao. The dynamic changes of circulating invariant natural killer T cells during chronic hepatitis B virus infection. Hepatology International 2016; 10(4) doi: 10.1007/s12072-015-9650-0
|
| 62 |
Aysegul Sari, Yelda Dere, Betul Pakoz, Aylin Calli, Belkis Unal, Mine Tunakan. Relation of hepatitis B core antigen expression with histological activity, serum HBeAg, and HBV DNA levels. Indian Journal of Pathology and Microbiology 2011; 54(2) doi: 10.4103/0377-4929.79972
|
| 63 |
Mona Abdel-Hady, Deirdre Kelly. Chronic Hepatitis B in Children and Adolescents: Epidemiology and Management. Pediatric Drugs 2013; 15(4) doi: 10.1007/s40272-013-0010-z
|
| 64 |
Neil D. Theise, Henry C. Bodenheimer, Linda D. Ferrell. MacSween's Pathology of the Liver. 2012; doi: 10.1016/B978-0-7020-3398-8.00007-6
|
| 65 |
Man Li, Xue-Hua Sun, Xiao-Jun Zhu, Shu-Gen Jin, Zhen-Jun Zeng, Zhen-Hua Zhou, Zhuo Yu, Yue-Qiu Gao. HBcAg induces PD-1 upregulation on CD4+T cells through activation of JNK, ERK and PI3K/AKT pathways in chronic hepatitis-B-infected patients. Laboratory Investigation 2012; 92(2) doi: 10.1038/labinvest.2011.157
|
| 66 |
Amr Abdelkader Fateen, Rasha Youssef Shahin, Mohamed Nazmy Farres, Mai Ahmed Eldeeb, Hanaa Ahmed Amer. Assessment of hepatic fibrosis and necroinflammation among inactive HBsAg carriers in Egypt. Annals of Hepatology 2012; 11(4) doi: 10.1016/S1665-2681(19)31459-0
|
| 67 |
Christos Liaskos, Athanasios Mavropoulos, Timoklia Orfanidou, Vassiliki Spyrou, Labrini V. Athanasiou, Charalambos Billinis. The immunopathogenetic role of autoantibodies in canine autoimmune hepatitis: lessons to learn from human autoimmune hepatitis. Autoimmunity Highlights 2012; 3(3) doi: 10.1007/s13317-012-0036-1
|
| 68 |
Agnieszka Lawrenczyk, Seil Kim, Xiangshu Wen, Ran Xiong, Weiming Yuan. Exploring the Therapeutic Potentials of iNKT Cells for Anti-HBV Treatment. Pathogens 2014; 3(3) doi: 10.3390/pathogens3030563
|
| 69 |
Jiafeng Ge, Haonan Zhao, Pengpeng Xie, Xingshun Qi, Chengwei Tang. Hepatitis - Recent Advances in 2025. 2025; doi: 10.5772/intechopen.1012683
|
| 70 |
Chia-Hsuin Chang, Jou-Wei Lin, Yu-Kang Tu. Secular trends were considered in the evaluation of universal hepatitis B vaccination in Taiwan. Journal of Clinical Epidemiology 2015; 68(4) doi: 10.1016/j.jclinepi.2014.11.014
|
| 71 |
Xinying Zhao, Xudong Guo, Libo Xing, Wenqin Yue, Haisen Yin, Miaoxia He, Jianmin Wang, Jianmin Yang, Jie Chen. HBV infection potentiates resistance to S-phase arrest-inducing chemotherapeutics by inhibiting CHK2 pathway in diffuse large B-cell lymphoma. Cell Death & Disease 2018; 9(2) doi: 10.1038/s41419-017-0097-1
|
| 72 |
Yu-Min Choi, So-Young Lee, Bum-Joon Kim. Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression. World Journal of Gastroenterology 2018; 24(16): 1708-1724 doi: 10.3748/wjg.v24.i16.1708
|
| 73 |
Edina Amponsah‐Dacosta, Ramokone L. Lebelo, J. Nare Rakgole, Rosemary J. Burnett, Selokela G. Selabe, M. Jeffrey Mphahlele. Evidence for a change in the epidemiology of hepatitis B virus infection after nearly two decades of universal hepatitis B vaccination in South Africa. Journal of Medical Virology 2014; 86(6) doi: 10.1002/jmv.23910
|
| 74 |
Rebecca T. Horvat, Ryan Taylor. Manual ofClinical Microbiology. 2015; doi: 10.1128/9781555817381.ch108
|
| 75 |
Shahd Mohamed Mustafa Abbas, Walla Saeed Eltahir Saeed, Osama Mohamed Musa, Mugtaba Elsamani Ahmed, Maria Mohamed H Satti, Brima Musa Younis, Ahmed Mudawi Musa, Eltahir Awad Gasim Khalil. Immune-pathological phases of chronic Hepatitis B infections among Sudanese individuals towards personalization of management. Journal of Human Virology & Retrovirology 2020; 8(1) doi: 10.15406/jhvrv.2020.08.00212
|
| 76 |
F. Pellegrini, M. Burgio, V. Cicirelli, G. Diakoudi, G. Elia, A. Salvaggiulo, N. Filipponio, F. Di Profio, V. Sarchese, J.P. Cavasin, V. Dahm, N. Decaro, M. Camero, G. Lanave, J.A. Beatty, B. Di Martino, V. Martella. Dynamics of domestic cat hepatitis B virus infection in juvenile cats. Veterinary Microbiology 2026; 316 doi: 10.1016/j.vetmic.2026.110956
|
| 77 |
M. Sui, R. Wu, X. Hu, H. Zhang, J. Jiang, Y. Yang, J. Niu. Low prevalence of hepatitis B virus infection in patients with autoimmune diseases in a Chinese patient population. Journal of Viral Hepatitis 2014; 21(12) doi: 10.1111/jvh.12302
|
| 78 |
Stephen G. Holt, Stephen Locarnini, Joe Sasadeusz. Hepatitis B related dilemmas in the renal unit. Nephrology 2021; 26(4) doi: 10.1111/nep.13815
|
| 79 |
Tonny Ssekamatte, John Bosco Isunju, Paul Alex Kimoga Zirimala, Samuel Etajak, Saul Kamukama, Mathias Seviiri, Mary Nakafeero, Aisha Nalugya, Solomon Tsebeni Wafula, Edwinah Atusingwize, Justine. N. Bukenya, Richard K. Mugambe. A positive attitude among primary healthcare providers predicts better hepatitis B prevention practices: evidence from a cross-sectional survey in Wakiso district, Central Uganda. Health Psychology and Behavioral Medicine 2021; 9(1) doi: 10.1080/21642850.2021.1904935
|
| 80 |
|
| 81 |
Neetu Rohit Kapoor, Vijay Kumar. Hepatitis B Virus: A Molecular Perspective. Proceedings of the National Academy of Sciences, India Section B: Biological Sciences 2012; 82(1) doi: 10.1007/s40011-011-0003-z
|
| 82 |
Wei Pan, Zuoqiao Wu, Shuwen Wu, Deyin Guo, Xiaoyan Gong, Tien Po. Human Immunodeficiency Virus Coinfection with Hepatitis B Virus Leads to a Decrease in Extracellular and Intracellular Hepatitis B Antigen. AIDS Research and Human Retroviruses 2015; 31(4) doi: 10.1089/aid.2014.0291
|
| 83 |
Matthew B Carroll. The impact of biologic response modifiers on hepatitis B virus infection. Expert Opinion on Biological Therapy 2011; 11(4) doi: 10.1517/14712598.2011.554810
|
| 84 |
DA-WU ZENG, YU-RUI LIU, JING DONG, YUE-YONG ZHU, YOU-BING LI, JING CHEN, QI ZHENG, JIA-JI JIANG. Serum HBsAg and HBeAg levels are associated with liver pathological stages in the immune clearance phase of hepatitis B virus chronic infection. Molecular Medicine Reports 2015; 11(5) doi: 10.3892/mmr.2015.3207
|
| 85 |
Hai‐hua Sun, Dong‐fang Zhou, Jun‐ying Zhou. The role of DCs in the immunopathogenesis of chronic HBV infection and the methods of inducing DCs maturation. Journal of Medical Virology 2016; 88(1) doi: 10.1002/jmv.24306
|
| 86 |
M. Estée Török. Manson's Tropical Infectious Diseases. 2014; doi: 10.1016/B978-0-7020-5101-2.00014-5
|
| 87 |
Stefan Wirth. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition. 2016; doi: 10.1007/978-3-319-17169-2_60
|
| 88 |
Zhao H. Hou, Qiu J. Han, Cai Zhang, Zhi G. Tian, Jian Zhang. miR146a impairs the IFN‐induced anti‐HBV immune response by downregulating STAT1 in hepatocytes. Liver International 2014; 34(1) doi: 10.1111/liv.12244
|
| 89 |
Colin C. Yost, Diana C. Jimenez, Matthew P. Weber, Elizabeth J. Maynes, Katherine A. Belden, Vakhtang Tchantchaleishvili, H. Todd Massey, David A. Sass, J. Eduardo Rame, John J. Zurlo, Nana Aburjania. Hepatitis B in Heart Transplant Donors and Recipients: A Systematic Review and Meta-Analysis. Journal of Surgical Research 2023; 283 doi: 10.1016/j.jss.2022.10.078
|